Mar 20, 2020
These are challenging times for governments, public health administrations and the financial markets. While each biopharma company’s primary concern is the health and safety of its team members, the industry also a responsibility to the world to take an active...
Jan 11, 2020
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our 2019 Annual Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life sciences deal...
Jan 11, 2020
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Medtech 2019 Annual Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the medtech deal...
Oct 11, 2019
Every quarter, Locust Walk’s medtech team compiles the latest statistics and trends on strategic medtech transactions and financings, with a focus on upcoming trends.
Oct 11, 2019
At the end of each quarter, our biopharma team here at Locust Walk reviews the global trends in biopharma transactions with an eye on future...
Sep 16, 2019
Based on recent acquisition activity by two of the largest pharmaceutical companies, it seems as if the historical orthodoxy that great biopharma companies are made from the inside out may be losing...
